1 protein, human papillomavirus type, human papillomavirus type6 l1 protein
Sold as Gardasil
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 1
- Registrations
- 1
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Gardasil 9 EACH 0,5 ml DOSE CONTAINS HUMAN PAPILLOMAVIRUS TYPE6 L1 PROTEIN 30,0 ug, HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN 40,0 ug,HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN 60,0 ug,HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN 40,0 ug,HU | 0,5 mLInjection | 51026451/30.1/0264Approved 18 August 2025 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.